drugset / Trial / NCT02714842

Delayed Release Diclofenac Sodium Formulation vs Voltaren®

NCT02714842

RandomizedCrossoverOpen-label

Summary

This is a single-centre, open-label, randomised, three-arm crossover study with a fourth fixed arm in a subset of subjects. Up to 36 healthy male volunteers will participate in the study. This study is designed to correlate the gastrointestinal transit behaviour of delayed-release diclofenac sodium tablets with their pharmacokinetic (PK) absorption profiles. The investigators will be looking at: 1. The behaviour of the tablets (when, where and how quickly they break up) 2. The gastric emptying time of the tablets (when they leave the stomach) 3. The gastrointestinal transit of the tablets (how long they take to travel through the gut) 4. Blood levels of the drug (diclofenac)

Timeline

Start
2016-03
Primary completion
2016-05
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 25 mg
Subject Diclofenac Other / unclassified 50 mg

Indications

No indication recorded.